R. Micán

发表

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients.

C. Barbas, I. Martínez, D. Rojo, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study.

C. Lumbreras, J. Macías, C. González-Domenech, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, E. Ribera, J. Macías, 2021, Open forum infectious diseases.

HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018

S. Reus, L. Force, C. Rodríguez, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

D. Podzamczer, E. Poveda, J. Arribas, 2021, Clinical Microbiology and Infection.

Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort.

J. Arribas, V. Moreno, R. Montejano, 2022, Enfermedades infecciosas y microbiologia clinica.

Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort.

J. Arribas, V. Moreno, R. Montejano, 2020, Enfermedades infecciosas y microbiologia clinica.

Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.

L. Martín-Carbonero, R. Micán, I. Pérez-Valero, 2021, AIDS.

Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services

M. Andreoni, K. Thomas, G. Whitlock, 2021, HIV medicine.

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

J. Arribas, J. Blanco, S. Moreno, 2021, HIV medicine.

Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.

J. Arribas, R. Delgado, V. Moreno, 2020, The Journal of antimicrobial chemotherapy.

Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418

H. Esteban, D. R. Crestelo, J. Cano, 2022, Open forum infectious diseases.

Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

R. Paredes, D. Podzamczer, M. Noguera-Julián, 2020, The Journal of antimicrobial chemotherapy.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients

J. Arribas, V. Moreno, R. Montejano, 2022, AIDS (London, England).

I. Martínez, J. Peraire, M. Pérez-Elías, 2021, Journal of Infection.

Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study

M. Díaz-Almirón, R. Montejano, L. Martín-Carbonero, 2022, HIV medicine.

PREVALENCE AND TEMPORAL TRENDS OF AUTOIMMUNE DISEASES IN PEOPLE LIVING WITH HIV.

M. Díaz-Almirón, R. Montejano, L. Martín-Carbonero, 2023, AIDS research and human retroviruses.

Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV.

J. Arribas, V. Moreno, L. Martín-Carbonero, 2023, Enfermedades infecciosas y microbiologia clinica.

Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data.

J. Arribas, V. Moreno, R. Montejano, 2022, AIDS (London).

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, J. Macías, S. Moreno, 2021, Open forum infectious diseases.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.

R. Micán, J. Bernardino, L. Ramos-Ruperto, 2024, HIV medicine.